HOFSETH BIOCARE ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.09 NOK | -0.48% |
|
-1.88% | -20.23% |
| Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
| Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 120M 11.47M | Sales 2023 | 219M 20.81M | Capitalization | 1.04B 98.58M |
|---|---|---|---|---|---|
| Net income 2022 | -137M -13.05M | Net income 2023 | -107M -10.19M | EV / Sales 2022 | 11.4 x |
| Net Debt 2022 | 71.74M 6.83M | Net Debt 2023 | 257M 24.47M | EV / Sales 2023 | 5.91 x |
| P/E ratio 2022 |
-8.89
x | P/E ratio 2023 |
-9.7
x | Employees | 70 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.78% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.48% | ||
| 1 week | -1.88% | ||
| Current month | +2.96% | ||
| 1 month | +1.46% | ||
| 3 months | -11.06% | ||
| 6 months | -23.72% | ||
| Current year | -20.23% |
1 week
2.05
2.15
1 month
1.932.27
Current year
1.902.76
1 year
1.903.95
3 years
1.908.28
5 years
1.9010.95
10 years
1.1210.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
| Director/Board Member | 53 | 15-04-30 | |
| Director/Board Member | 49 | 15-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 2.09 | -0.48% | 12 692 |
| 24-05-28 | 2.1 | -2.33% | 26,498 |
| 24-05-27 | 2.15 | 0.00% | 4,979 |
| 24-05-24 | 2.15 | +2.38% | 25,169 |
| 24-05-23 | 2.1 | -1.41% | 47,570 |
Real-time Oslo Bors, May 29, 2024 at 03:06 am EDT
More quotes
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Companyâs business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Sector
Food Processing
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -20.23% | 79.17M | |
| -6.08% | 264B | |
| -6.71% | 90.64B | |
| -5.22% | 42.56B | |
| +0.24% | 41.13B | |
| +5.99% | 39.96B | |
| +2.36% | 37.64B | |
| -15.69% | 30.11B | |
| -7.21% | 28.41B | |
| +12.55% | 25.17B |
- Stock Market
- Equities
- HBC Stock
